Abstract:Summary
Background
Temporary faecal diversion is sometimes used for management of refractory perianal Crohn's disease (CD) with variable success.
Aims
To perform a systematic review with meta‐analysis to evaluate the effectiveness, long‐term outcomes and factors associated with success of temporary faecal diversion for perianal CD.
Methods
Through a systematic literature review through 15 July 2015, we identified 16 cohort studies (556 patients) reporting outcomes after temporary faecal diversion. We estimated… Show more
“…57,60 Additionally, patients undergoing rectal resection or temporary faecal diversion for perianal disease control have a higher rate of permanent faecal diversion. 55,61 Patients with permanent stoma have typically experienced a greater number of previous abdominal surgeries than those without a permanent stoma. 55,59 It is important to acknowledge that the likelihood of successful stoma reversal after temporary diversion for control of perianal sepsis or disease is low.…”
Background and Aims:Efforts to slow or prevent the progressive course of inflammatory bowel diseases [IBD] include early and intensive monitoring and treatment of patients at higher risk for complications. It is therefore essential to identify high-risk patients – both at diagnosis and throughout disease course.Methods:As a part of an IBD Ahead initiative, we conducted a comprehensive literature review to identify predictors of long-term IBD prognosis and generate draft expert summary statements. Statements were refined at national meetings of IBD experts in 32 countries and were finalized at an international meeting in November 2014.Results:Patients with Crohn’s disease presenting at a young age or with extensive anatomical involvement, deep ulcerations, ileal/ileocolonic involvement, perianal and/or severe rectal disease or penetrating/stenosing behaviour should be regarded as high risk for complications. Patients with ulcerative colitis presenting at young age, with extensive colitis and frequent flare-ups needing steroids or hospitalization present increased risk for colectomy or future hospitalization. Smoking status, concurrent primary sclerosing cholangitis and concurrent infections may impact the course of disease. Current genetic and serological markers lack accuracy for clinical use.Conclusions:Simple demographic and clinical features can guide the clinician in identifying patients at higher risk for disease complications at diagnosis and throughout disease course. However, many of these risk factors have been identified retrospectively and lack validation. Appropriately powered prospective studies are required to inform algorithms that can truly predict the risk for disease progression in the individual patient.
“…57,60 Additionally, patients undergoing rectal resection or temporary faecal diversion for perianal disease control have a higher rate of permanent faecal diversion. 55,61 Patients with permanent stoma have typically experienced a greater number of previous abdominal surgeries than those without a permanent stoma. 55,59 It is important to acknowledge that the likelihood of successful stoma reversal after temporary diversion for control of perianal sepsis or disease is low.…”
Background and Aims:Efforts to slow or prevent the progressive course of inflammatory bowel diseases [IBD] include early and intensive monitoring and treatment of patients at higher risk for complications. It is therefore essential to identify high-risk patients – both at diagnosis and throughout disease course.Methods:As a part of an IBD Ahead initiative, we conducted a comprehensive literature review to identify predictors of long-term IBD prognosis and generate draft expert summary statements. Statements were refined at national meetings of IBD experts in 32 countries and were finalized at an international meeting in November 2014.Results:Patients with Crohn’s disease presenting at a young age or with extensive anatomical involvement, deep ulcerations, ileal/ileocolonic involvement, perianal and/or severe rectal disease or penetrating/stenosing behaviour should be regarded as high risk for complications. Patients with ulcerative colitis presenting at young age, with extensive colitis and frequent flare-ups needing steroids or hospitalization present increased risk for colectomy or future hospitalization. Smoking status, concurrent primary sclerosing cholangitis and concurrent infections may impact the course of disease. Current genetic and serological markers lack accuracy for clinical use.Conclusions:Simple demographic and clinical features can guide the clinician in identifying patients at higher risk for disease complications at diagnosis and throughout disease course. However, many of these risk factors have been identified retrospectively and lack validation. Appropriately powered prospective studies are required to inform algorithms that can truly predict the risk for disease progression in the individual patient.
“…Perianal CD is an extremely disabling condition that can impact on the physical, psychosocial, and sexual life of patients . CD‐pAF patients may require multiple surgeries with associated morbidity and work impairment, which can lead to permanent disability due to radical surgery, such as proctectomy and permanent stoma . Perianal disease is also a risk factor for more disabling course of the disease on the long term …”
Section: Discussionmentioning
confidence: 99%
“…The need for repeat surgical interventions may indicate uncontrolled or poorly controlled state in CD‐pAF status and can be a measure for evaluating success of initial multimodality approach. Furthermore, CD‐pAF is associated with a high risk of radical surgery (such as defunctioning ± proctectomy which often leads to a definitive stoma) and, consequently, with a permanent disability for the patients …”
Multimodality treatment, anti-TNFs use, and removal of setons after multimodality treatment can result in improved outcomes in CD patients with perianal fistulae and reduce the need for repeat surgery and radical surgery.
“…Although the adult patient sample size was limited, in only the colon-like CD subclass were there patients with rectal disease, or that required a colectomy. Rectal CD is particularly difficult to manage, and though it may represent a unique CD phenotype, its underlying molecular mechanisms are unknown[22, 23, 24]. Pediatric patients with colon-like disease were more likely to have macroscopic inflammation, deep ulcers, and involvement of both the ileum and colon.…”
Objective
The clinical presentation and course of Crohn’s disease (CD) is highly variable. We sought to better understand the cellular and molecular mechanisms that guide this heterogeneity, and characterize the cellular processes associated with disease phenotypes.
Design
We examined both gene expression and gene regulation (chromatin accessibility) in non-inflamed colon tissue from a cohort of adult CD and control patients. To support the generality of our findings, we analyzed previously published expression data from a large cohort of treatment-naïve pediatric CD and control ileum.
Results
We found that adult CD patients clearly segregated into two classes based on colon tissue gene expression—one that largely resembled the normal colon and one where certain genes showed expression patterns normally specific to the ileum. These classes were supported by changes in gene regulatory profiles observed at the level of chromatin accessibility, reflective of a fundamental shift in underlying molecular phenotypes. Further, gene expression from the ilea of the treatment-naïve pediatric CD patient cohort could be similarly subdivided into colon- and ileum-like classes. Finally, expression patterns within these CD subclasses highlight large-scale differences in the immune response and aspects of cellular metabolism, and were associated with multiple clinical phenotypes describing disease behavior, including rectal disease and need for colectomy.
Conclusion
Our results strongly suggest that these molecular signatures define two clinically relevant forms of CD irrespective of tissue sampling location, patient age or treatment status.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.